Mandatory reading: Alan Carr’s in-depth review of the antibiotic landscape
Dear All: Alan Carr (acarr@needhamco.com, Needham & Company, LLC) writes a superb investment-focused newsletter focused on the antibiotic sector. We all owe him a debt
30 March 2019
No Comments